Finally, BiTEs are known to induce T-cell proliferation following activation,27 39 and so NKG2D BiTE-mediated activation may trigger TIL expansion in the GBM TME, increasing the number of effector cells for BiTE therapy. Here, KLRK1 is linked to glioblastoma.